Clinical predictors of malignancy in palatal salivary gland tumors.


Journal

Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 27 04 2019
revised: 12 08 2019
accepted: 17 08 2019
pubmed: 25 8 2019
medline: 1 1 2020
entrez: 25 8 2019
Statut: ppublish

Résumé

To establish a predictive clinical index of malignancy risk in palatal salivary gland tumors (PSGT). One hundred cases of PSGT were evaluated. Clinical data were retrieved from the patient's files. Representative clinical photographs of each tumor were evaluated to identify clinical features suggestive of a malignant tumor. Features significantly associated with malignancy were included in a binary logistic regression model. Malignant tumors were more common in the hard palate, in women and in older patients. Features associated with a malignant diagnosis included pain (p = .017), irregular surface (p = .004), bluish/purple coloration (p < .001), ulceration (p = .005), and telangiectasia (p = .015). After multivariate logistic regression, pain (OR: 4.017; 95% CI: 1.198-13.471; p = .024) and color alteration (OR: 7.243; 95% CI: 2.068-25.363; p = .002) were independently associated with malignancy. Including these factors in a predictive index, the proportion of malignant tumors in patients presenting none, one and two factors were 25% (95% CI: 0.13-0.40), 67% (95% CI: 0.48-0.83), and 85% (95% CI: 0.42-0.99), respectively. Pain and color alteration might be independent predictors of malignancy in PSGT, which could support the decision to perform an incisional or excisional biopsy.

Identifiants

pubmed: 31444932
doi: 10.1111/odi.13181
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1919-1924

Subventions

Organisme : Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
ID : Finance code 001
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : Alan Roger Santos-Silva is a research grantee

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.

Références

Beckhardt, R. N., Weber, R. S., Zane, R., Garden, A. S., Wolf, P., & Carrillo, R.… Luna, M. A. (1995). Minor salivary gland tumors of the palate: Clinical and pathologic correlates of outcome. Laryngoscope, 105, 1155-1160.
Buchner, A., Merrell, P. W., & Carpenter, W. M. (2007). Relative frequency of intra-oral minor salivary gland tumors: A study of 380 cases from northern California and comparison to reports from other parts of the world. Journal of Oral Pathology and Medicine, 36, 207-214.
Chi, A. C., & Neville, B. W. (2015). Surface papillary epithelial hyperplasia (Rough Mucosa) is a helpful clue for identification of polymorphous low-grade adenocarcinoma. Head and Neck Pathology, 9, 244-252.
Copelli, C., Bianchi, B., Ferrari, S., Ferri, A., & Sesenna, E. (2008). Malignant tumors of intraoral minor salivary glands. Oral Oncology, 44, 658-663.
Egal, E. S., Mariano, F. V., Altemani, A. M., & Metze, K. (2018). Age and adenoma size are independent risk factors for the development of carcinoma ex pleomorphic adenoma. Oral Oncology, 84, 106-107.
Eveson, J. W., & Cawson, R. A. (1985). Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. The Journal of Pathology, 146, 51-58.
Ito, F. A., Ito, K., Vargas, P. A., de Almeida, O. P., & Lopes, M. A. (2005). Salivary gland tumors in a Brazilian population: A retrospective study of 496 cases. International Journal of Oral and Maxillofacial Surgery, 34, 533-536.
Jansisyanont, P., Blanchaert, R. H., & Ord, R. A. (2002). Intraoral minor salivary gland neoplasm: A single institution experience of 80 cases. International Journal of Oral and Maxillofacial Surgery, 31, 257-261.
Lee, S.-Y., Shin, H. A., Rho, K. J., Chung, H. J., Kim, S.-H., & Choi, E. C. (2013). Characteristics, management of the neck, and oncological outcomes of malignant minor salivary gland tumours in the oral and sinonasal regions. British Journal of Oral and Maxillofacial Surgery, 51, e142-e147.
Lloyd, S., Yu, J. B., Ross, D. A., Wilson, L. D., & Decker, R. H. (2010). A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. International Journal of Radiation Oncology*Biology*Physics, 76, 169-175.
Loyola, A. M., de Araújo, V. C., de Sousa, S. O. M., & de Araújo, N. S. (1995). Minor salivary gland tumours. A retrospective study of 164 cases in a Brazilian population. European Journal Cancer Part B Oral Oncology, 31, 197-201.
Moore, B. A., Burkey, B. B., Netterville, J. L., Butcher, R. B., & Amedee, R. G. (2008). Surgical management of minor salivary gland neoplasms of the palate. The Ochsner journal, 8, 172-180.
Pires, F. R., Pringle, G. A., de Almeida, O. P., & Chen, S.-Y. (2007). Intra-oral minor salivary gland tumors: A clinicopathological study of 546 cases. Oral Oncology, 43, 463-470.
Sentani, K., Ogawa, I., Ozasa, K., Sadakane, A., Utada, M., Tsuya, T.… Yasui, W. (2019). Characteristics of 5015 salivary gland neoplasms registered in the Hiroshima tumor tissue registry over a period of 39 years. Journal of Clinical Medicine, 8, 566.
Waldron, C. A., El-Mofty, S. K., & Gnepp, D. R. (1988). Tumors of the intraoral minor salivary glands: A demographic and histologic study of 426 cases. Oral Surgery, Oral Med Oral Pathol, 66, 323-333.
Wang, X., Meng, L., Hou, T., Zheng, C., & Huang, S. (2015). Frequency and distribution pattern of minor salivary gland tumors in a Northeastern Chinese population: A retrospective study of 485 patients. Journal of Oral and Maxillofacial Surgery, 73, 81-91.
Zheng, Y., Xiao, Z., Zhang, H., She, D., Lin, X., Lin, Y., … Cao, D. (2018). Differentiation between benign and malignant palatal tumors using conventional MRI: A retrospective analysis of 130 cases. Oral Surg Oral Med Oral Pathol Oral Radiol, 125, 343-350.

Auteurs

Bruno Augusto Linhares Almeida Mariz (BALA)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.

Patricia do Socorro Queiroz Feio (P)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.

Ana Luiza Oliveira Corrêa Roza (ALOC)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.

Bruno Augusto Benevenuto de Andrade (BAB)

Department of Oral Diagnosis and Pathology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.

Michelle Agostini (M)

Department of Oral Diagnosis and Pathology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.

Mário José Romañach (MJ)

Department of Oral Diagnosis and Pathology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.

Felipe Paiva Fonseca (FP)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.
Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Helder Antonio Rebelo Pontes (HAR)

Service of Oral Pathology, João de Barros Barreto University Hospital, Federal University of Pará, Belém, Brazil.

Ana Carolina Prado Ribeiro (ACP)

Dental Oncology Service, Instituto do Câncer do Estado de São Paulo, ICESP-FMUSP, São Paulo, Brazil.

Thaís Bianca Brandão (TB)

Dental Oncology Service, Instituto do Câncer do Estado de São Paulo, ICESP-FMUSP, São Paulo, Brazil.

Andre Caroli Rocha (AC)

Clinics Hospital of the Medical School of the University of São Paulo, São Paulo, Brazil.

Pablo Agustin Vargas (PA)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.

Marcio Ajudarte Lopes (MA)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.

Alan Roger Santos-Silva (AR)

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH